<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 282 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page281.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=282">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 282 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 282</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=282"><img src="../thumb/282.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials -  18.8 / 18.8.1                                               2020-04 / 245
                                     dinav. /fluconazole/clarithromyc.incr.AUC, AUC of concom.indinav./  Dosage: Continuat.phase of pulm.TB treatm. admin. on an intermitt.
       18.8   Mycobacteria           saquinav./dapsone/ clarithromyc. decr., concom.ritonav.incr.AUC &   basis on an empty stomach as a sngl.dos. Tabs.can be halv.to titrat.
                                                                  accurat. Max. dly.dos.for any child.is 6 tabs.
                                     C max, AUC & C max of concom.zidovud./itraconaz.decr. cover of con-
                                     com.OC poss.not adeq., tacrolim. trough bld.lev.decr., cross resist.  Treatm: Tot.dos.requirem.is rifampicin 10 mg/kg & Isoniazid 10 mg/
       18.8.1  Tuberculostatics      with rifampicin., protease inhibits.act as substrates/inhibit.of CYP450   kg 3x/wk. This can be achiev.by giv. 1 tab.per 5 kg bm. Infts/Childr:
                                                                  3 kg up to &lt;5 kg: ½ tab; 5 kg up to &lt;7,5 kg: 1 tab; 7,5 kg up to
                                     IIIA4 mediat.metabol.
              (See also 18.7)        PASER, Equity [P/S]          &lt;10 kg; 1,5 tabs; 10 kg up to &lt;15 kg: 2 tabs; 15 kg up to &lt;20 kg:
                                                                  3 tabs; 20 kg up to &lt;25 kg: 4 tabs; 25 kg up to &lt;30 kg: 5 tabs; 30
       BE-TABS ISONIAZID, Ranbaxy [P/S]  p-Aminosalicylic acid    kg up to &lt;35 kg: 6 tabs.
       Isoniazid                     Indications: TB treatm.in conjunct. with other act. anti- TB agents   Chemoprophylax: Childr.&lt;5 yrs.liv.in close contact with smear posit.
       Indications: Pulm.TB & extrapulm.les.ie meningit., high.risk pts.for   mostly in pts.with multidrug resistant TB or when isoniazid/rifampin   indiv.to be treat.x 3 mnths. Routine chemoprophylax.not recomm.
       prophylax., lupus vulgar.     ther.not poss. due to combin.of resist.and/or intol.  for childr.over 5 yrs.
       (S3) TABS. E/20.2.3/108       Admin.with at least one & pref.2 other agents to which organism is   Contraindications: Jaund., liv.damage, safety in pregn.& lac-
       823589-005: 100 mg, 1000, R137,06  known/expect.to be suscept.  tat.not est.
       Dosage: Admin on an empty stomach.  (S4) DELAY.REL.GRANS. 45/20.2.3/0037  Side effects: Fev., flu-like syndr., skin rash, ren. fail., bld.dyscras.,
       TB: Admin.concurr.with other tuberculostat. Usual dos: 4-5 mg/kg   711116-002: 4 g/sach., 30, R1 120,75  GI disturbs., pseudomembr. colit., menstr.disturbs., orange-red dis-
       bm dly. in sngl./div.dos. Max. 300 mg dly.  Dosage: Sprinkle on apple sauce/yoghurt or by swirl.the glass to   col.of urine, sputum & tears, CNS effs., musc.weakn., atax., periph.
       TB Meningit: Admin. concurr.with other tuberculostat. Dos.up to 10   susp.grans.in an acid.drink e.g. tomato/ orange juice. Do not use if   neuropathy, blurr.vis., trans.hear.loss, shock, polyneurit., convuls.
                 nd
               st
       mg/kg bm dly. dur.1 / 2  week of treatm.  gran.discol./ loose tan col.  with high dos.isoniazid, psychot.reacts., lupus-like reacts., pellagra,
       TB prophylax: 300 mg dly.x12 mnths.or long.  Adults: 4 g 3x/day. Infts./childr.& adolesc: 200-300 mg/kg 2-4xdly   hyperglycaem., rheumat.syndr., gynaecomast., urin.retent., metabol.
       Contraindications: Drug-induc.liv.dis., convuls. disords., chron.al-  to max.dos.of 10 g dly.  acidos., hypersens.reacts.
       cohol., imp.liv./ren.funct.   Contraindications: Sev.ren./hepat.dis.  Special precautions: Imp.liv./ren.funct., diab. mellit., chron.alco-
       Side effects: . Periph./optic neurit., psychot. reacts., convuls., CNS   Side effects: Freq: Fev., skin rashes/itch., eosinophil., leucocytos.,   hol., gout hist., convuls.disords., ac. porphyr., monit.liv.funct.& for pro-
       effs., neurotox.effs. hypersens. reacts., sev.skin erupt.incl.erythema   N&V, diarrh., abdom. pain. Less freq: Antiglobul.posit.haemolyt.   drom.signs of hepatit., discont.if S&S of hepatocellul.damage occur,
       multiforme, vasculit., hepatit., bld.dyscras., sev.liv damage, GI dis-  anaem.in G6PD defic., megaloblast.anaem.due to vit B 12 defic., hy-  soft cont.lens.stain, supplem.Vit.B6 treatm. esp. in those predispos.to
       turbs., dry mouth, urin.retent., methaemoglobinem., tinnit., pellagra,   persens.reacts.incl.arthralg./ lymphadenopathy, hepatosplenomeg./  neuropathy, elderly, epilep., poss.period.eye examinat.with isoniazid,
       hyperglycaem., lupus-like syndr., gynaecomast.  infect. mononucleos. syndr./jaund./hepatit./ encephalopathy/ leuco-  non-horm. contracept.advocat.
       Special precautions: Prophylact.pyridoxine 100-200 mg dly.  pen./agranulocytos./ thrombocytopen./ pericardit./hypoglycaem./  Drug interactions: Halothane incr.hepatotox.of both compds.,
       recomm.for periph.neurit.counteract., pts. at risk of neuropathy/  opt. neurit./eosinophil.pneumon./vasculit./prothromb.reduct., vit.  ketoconazole dimin.conc.of both compds., rifampicin reduc.activ.
       pyridoxine defic., diabet., alcohol., malnourish., uraem., pregn., dis-  B 12 & Fe defic., depress.cholesterol, goitre/ hypothyroid., psychos.,   of azathioprine, chloramphenicol, cimetidine, clofibrate, corticos-
       cont.if sympts. of hepatit.devel., pre-exist.liv.dis., resist.in monother.   hepatit., steatorrh., crystallur.  ter., coumar.anticoags., cyclospor, dapsone, diazepam, doxycycl.,
       except when used as prophylax., caref. monit. in black & Hispanic   Warnings and special precautions: Ren. impairm., gastr.ulc.,   fluconazole, haloperidol, hexobarbitone, itraconazole, ketocona-
       women, period.eye exam.       G6PD defic., maint.Vit.B 12 if on treatm.long.than 1 mnth., incompl.   zole, methadone, oral hypoglycaem. agents, phenytoin, quinine,
       Drug interactions: Enhanc.eff.of phenytoin, incr. toxic.with disulfi-  malabsorpt. syndr. poss.devel., hepat.impairm./-dis., monit.pts.caref.  sulphasalazine, thyroid hormones, theophylline, zidovudine &
                                               st
       ram./anti-epilept/benzodiazepines & theophylline,, incr.hepatotoxic.  for signs of hepatit.dur.1  3 mnths.& treatm. to be discont.immed.at   sever.CV drugs incl.ß-adrenocept.block.agents, digitoxin, digoxin,
       risk with concom. rifampicin/ other pot.hepatotox.drugs., potent. ne-  first rash/ fev./other premonit.intol.signs, discont.all meds. if hyper-  anti-arrhythmic agents, Ca chann.block, OC’s, narcot., analges.&
       phrotox.lev.of fluoride aris.from incr.metabol.of enflurane, incr.toxic.  sens.reacts.occur & restart one at a time determ.wheth.reacts.are   barbitur., antacids reduc. bioavail.of rifampicin, as an inhibit.
       of cycloserine & warfarin.    meds-induc./ which meds.respons., safety & effic.in pregn.& lactat.  of hepat.drug metabol.isoniazid may enhance some meds.effs.,
                                     not est., pass.into breast milk.  isoniazid incr.theophyll.plasma conc., isoniazid incr.CNS adverse
       ETHATYL, Sanofi-Aventis [P/S]  Interactions: Reduct.in acetylat.of isoniazid, poss. reduc.Vit.B 12 ab-  effs.of cycloserine & disulfiram, alcoh., aminosalicylic acid, ant-
       Ethionamide.                  sorpt., reduc.ser.digox.lev., ethionamide poss.intens.adverse reacts.,   acids, corticoster., ketoconazole, propranol & large dos.pyridox
       Indications: Mycobact.TB sens.strains, 2  line treatm.in combi-  diphenylhydramine decr.GI absorpt.  can aff.isoniazid.
                         nd
       nat.with other effect.agents/ where resist./contra-indications ex-
       ist to prim. agents.          R-CIN 600, Pharma Dynamics [P/S]  SANDOZ ETHAMBUTOL HCl 400, Sandoz [P/S]
       (S3) TABS. A98.               Rifampicin.                  Ethambutol HCl.
       724599-002: 250 mg, 250, R759,81  Indications: Combinat.therapy in TB, chemoprophylax.of menin-  Indications: TB in conjunct.with other TB agents.
       Dosage: Admin.in div.dos.with meals or at bedt.  gococc.dis & meningit., leprosy in combinat.with other anti-leprosy  (S3) TABS. Q/20.2.3/176.
       Adults: 15-20 mg/kg/day. Max.dly.dos: 1 g Childr: Over 10 yrs: as   (S4) CAPS. 32/20.2.3/0308.  724610-015: 400 mg, 56, R81,13
       for adults. Und.10 yrs: 10  mg/kg/day incr.grad.to 15-20 mg/kg/day.   704046-001: 600 mg, 100, R634,10  724610-016: 400 mg, 84, R121,77
       Max.dly.dos: 750 mg           Dosage: Admin.on empty stomach. Dly.treatm. gen. bett.tol.  724610-017: 400 mg, 60, R86,93
       Contraindications: Pregn., safety in lactat.not est., sev.hepat.dis.   TB: Addit.anti-tubercul.agents to be prescrib. concom. Adults & chil-  724610-006: 400 mg, 100, R144,98
       Side effects: GI disturbs., hepatit., jaund., CNS effs.incl.convuls.&   dr: Contin.regim: Sngl.dly dos.10 mg/kg bm. Max.dly.dos: 600 mg.   Dosage: Prim.treatm: 15 mg/kg 1xdly.
       periph.neuropathy, hypersens. reacts., alopec., photosens., arthralg.,   Intermitt.regim: Sngl.dly.dos.15 mg/kg bm 2-3x/wk. Max.900 mg.  Re-treatm: 1st 60 days: 25 mg/kg 1xdly, thereaft. 15 mg/kg.
       amenorrh., gynaecomast., impot., hypoglycaem., hypothyroid.  Leprosy: Prescr.in combinat.with other anti-leprot. agents. Adults:   Contraindications: Childr.und.13 yrs.
       Special precautions: Porphyr., epilep., diffic. diab. contr., de-  600 mg once/mnth. Adults weigh.&lt;35 kg & childr.10-14 yrs: 450   Side effects: Opt.neurit., allerg.rash., joint pain, GI disturbs., CNS
       press., psych.disords., liv.impairm., chron.alcohol., hypothyroid.,   mg mnthly. Low body-weight childr: 12-15 mg/kg bm mnthly.  eff., periph.neurit., anaphylax., leucopen., drug fev., prurit., malaise.
       liv.funct.tests bef./ mnthly. dur.treatm., discont.treatm.if sev.incr.in   Menigococc.carriers: Adults: 600 mg 2x/day for 2 days. Chil-  Special precautions: Imp.ren.funct., reduc.vis. acuity.
       hepat. enzyme lev.even if no sympt., concomm. pyridoxine recomm.  dr.1-12 yrs: 10 mg/kg bm 2x/day for 2 days. 3-I2 mnths: 5 mg/kg
       to prev.neurotox.S/E          bm 2x/day for 2 days.        SANDOZ PYRAZINAMIDE 500, Sandoz [P/S]
                                                                  Pyrazinamide.
       Drug interactions: Cross resist.with thioacetazone, addit.neurolog.  Prophylax.of H.Influenzae meningit: Adults & childr.over 3
       effs.with isoniazid, incr.CNS toxic.risk with cycloserine & terizidone  mnths: 20 mg/kg bm dly x4 days. Max.dly.dos: 600 mg  Indications: Mycobacterium TB infects.
                                                                  (S3) TABS. R/20.2.3/153.
       MYCOBUTIN, Pfizer [P/S]       Contra-indications: Jaund., liv.impairm., safety in pregn.& lactat.  761583-018: 500 mg, 28, R43,27
                                     not est., furth.rifampic.if thrombocytopen.& purpura develops with
       Rifabutin.                    intermit. TB regimens.       761583-019: 500 mg, 56, R86,68
       Indications: Sens.pulm.TB resist.to rifampicin in combinat. with   Side-effects: Red.discolourat.body fluids/ secret., cutan.reacts.2-3   761583-020: 500 mg, 84, R130,02
       other meds.not belong.to the rifamycin group, M.avium intracellu-  hrs.aft dos.as fac.flush./itch./ rash/ eye irrit., flu-like syndr., hypersens.  761583-009: 500 mg, 100, R159,30
       lare complex (MAC)/M.xenopi infects.of both disseminat.& localis.   reacts. incl.anaphylax., haemoglobinur., haematur., ren. insuffic., GI   761583-017: 500 mg, 1 000, R1 548,88
       dis.also in immuno-comprom.HIV posit. pts., MAC infect.prophylax   disturbs.incl.pseudomembr.colit., trans. liv.funct.abnormalit., hepatit.,   Dosage: 20-35 mg/kg bm to max.of 3 g dly in 3-4 div.doses in
       in advan.HIV infect.          leucopen., haemolyt.anaem., CNS effs., numbn., vis.disturbs., musc.  combinat.therapy.
       (S4) CAPS. Z/20.1.1/395.      weakn., immunoglobin.light chain proteinur. & ren.fail.  Contraindications: Hepat.dysfunct., safety in childr.& pregn.not est.
       809748-010: 150 mg, 30, R439,27  Special precautions: Dly.treatm.better tol.than intermitt.ther., self-  Side effects: Fev., anorex., malaise, liv.tendern., hepatospleno-
       Dosage: As sngl.dly.dos.in combinat.regimens. Adults with   limit.hyperbilirubinaem. exper. in 1  2-3 wks.does not indicat.withdr.  megaly, N&V, arthralg., dysur., sideroblast. anaem., diffic.micturit.,
                                                   st
       bm.&gt;35 kg.                    if other liv. funct.tests are within norm.limits., discont.in presc. of   photosensit., skin rash., uric acid plasma conc.incr.
       New diagn.pulm.TB: 1 cap.dly.x6 mnths.  other evid.of hepat.funct.impairm., if purpura/ thrombocytopaen./  Special precautions: Hepat.funct.studies., imp. ren. funct., dia-
       Chron.rifampic.-resist.pulm.TB: 2-3 caps.dly. for up to 6 mnths   haemolyt.anaem./ ren.fail. develop.discont.perman., always pre-  bet.mellit., gout hist.
       aft.negat.sput.cult.          scribe in combinat.with other antibiot./chemother.agents to prev.  TERIVALIDIN, Sanofi Aventis
       Atypic.mycobact.infects: 3-4 caps.dly.for up to 6 mnths.aft.  emerg.of rifampic.-resist.bact.  Terizidone
       negat.cult.                   Warning: M.fortuitum is rifampicin resist., chron.liv.dis./alcohol.&   Indications: As part of multidrug regime for tubercular lesions at all
       MAC prophylax.in advanc.HIV infects: 2 caps.dly.  old age incr.incid.of sev.hepat.probl., admin.follow.treatm.interrupt.   stages of infect.esp. where resist.to other drugs evid.
       Contra-indications: Safety in pregn., lactat., childr.& adolesc.  assoc. with incr.risk of ser.adverse effs., fatal. report.with pre-exist.  (S3) CAPS, A180
       not est.                      liv.disords.& other hepatotox. agents., orange red stain.of body flu-  769797-009: 250 mg, 100, R2 447,25
       Side-effects: Red-orange col.to urine, poss.skin & body secret., corn.  ids & soft contact lenses.  Dosage: Adults: 1 cap.6-8 hrly.or as prescrib.
       deposits., skin pigmentat./ discolour., GI disturbs.incl.CDAD, rash,   Drug interactions: Half life of prednisone/ digitoxin/ quinidine/  Contra-indications: Sev.ren.insuffic.
       erythem., dermatit., bronchosp., eosinophil., shock, itch., prurit., bld.   ketoconazole/propranol./ metoprol. /clofibrate/sulphonureas & oral   Side-effects: Headache, dizzin., trem., convuls., dysarthr., mania,
       dyscras., jaund., incr.hepat.enzym., pyrex, asthen., alopec., atax., vis.  coumar. anticoags.decr., OC’s effective.decr., methadone metabol.incr.  depress., GI irrit.
       disturb., mild to sev. revers.uveitis, risk incr.when admin.in dos. above   precipitat.poss.withdr.sympts., bil. excret.of contrast media reduc.,   Special precautions: Epilepsy, ment.dis., chron. alcohol.
       300 mg in combinat.with clarithromycin & fluconazole, arthralg., my-  other meds.also affect.incl. dapsone/hexobarbitone/diazepam./ flu-
       alg., incr. alkalin. phosphat./ALT/AST, abnorm.LFT, incr.transaminas.  conazole/itraconazole/phenytoin/sulphasalazine/thyroid hormones/  WINTHROP-ISONIAZID, Sanofi-Aventis [P/S]
       Special precautions: Sev.ren./hepat.impairm., soft contact lenses   disopyramide/ioreamide/ mexiletine /propafeone/tocainide/vera-  Isoniazid
       discolourat., concom. clarithromycin, other macrolides &/flucona-  pamil/ theophylline/chloramphenicol & cyclosporine, bioavail.reduc.  Indications: TB prophylax., TB treatm.in conjunct. with other meds.
       zole, if act.TB develops other anti-TB medic.to be add., monit.liv.  by antacids & bentonite, clofazimine decr.absorpt.  (S3) TABS. A17, C/20.2.3/194
       enzym.,white bld.cell & platel.counts, addit.contracept.for OC users,   732966-020: 100 mg, 84, R22,39
       isoniazid may incr. severity& freq. of haematolog.reacts., discont.if   RIMACTAZID PAED 60/60, Sandoz [P/S]  732958-017: 300 mg, 28, R33,15
       uveit.occ. & ref.to ophthalmolog., consid.CDAD in pts. present.with   Rifampicin 60 mg, isoniazid 60 mg.  Dosage: Admin with meals.
       diarrh.follow.Rifabut.use     Indications: Pulmon.TB in childr.  Adults: Usual: 100 mg 3x dly. Recomm.dos: 3-5 mg/kg bm every 24
       Drug interactions: Plasma conc.of drugs metabol. by CYP450 IIIA4   (S4) 60/60 TABS 32/20.2.3/0548.  hrs.in 2 or more dos.
       poss.reduc., plasma conc. incr.by CYP450 IIIA4 inhibits., concom. in-  863971-025: 28, R45,99  Childr: 10-20 mg/kg bm dly</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page281.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page277.html">277</a>&nbsp;&nbsp;&nbsp;<a href="page278.html">278</a>&nbsp;&nbsp;&nbsp;<a href="page279.html">279</a>&nbsp;&nbsp;&nbsp;<a href="page280.html">280</a>&nbsp;&nbsp;&nbsp;<a href="page281.html">281</a>&nbsp;&nbsp;&nbsp;<a href="page282.html">282</a>&nbsp;&nbsp;&nbsp;<a href="page283.html">283</a>&nbsp;&nbsp;&nbsp;<a href="page284.html">284</a>&nbsp;&nbsp;&nbsp;<a href="page285.html">285</a>&nbsp;&nbsp;&nbsp;<a href="page286.html">286</a>&nbsp;&nbsp;&nbsp;<a href="page287.html">287</a>
             </td>
             <td width="35%"><a href="page283.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page283.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
